Low-dose intramuscular revaccination against hepatitis B

Vaccine

Volumn 14, Issue 17-18, 1996, Pages 1647-1650

  Ramon, Josep Ma ^a   Bou, Ricardo ^a   Oromi, Joaquin ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

hepatitis B vaccine; low booster dose; revaccination

Indexed keywords

HEPATITIS B VACCINE; RECOMBINANT VACCINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HIGH RISK POPULATION; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVACCINATION;

ADULT; DOUBLE-BLIND METHOD; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; STATISTICS; VACCINATION; VACCINES, SYNTHETIC;

EID: 0030452080     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(96)00134-X     Document Type: Article

References (18)

1. 1 Hadler, S.C., Doto, I.L., Maynard, J.E. et al. Occupational risk of hepatitis B infection in hospital workers. Infect. Control 1985, 6, 24-31
2. 2 Jilg, W., Schimdt, M. and Deinhart, F. Decline of anti-HBs after hepatitis B vaccination and timing of revaccination. Lancet 1990, 335, 173-174
3. 3 Laplanche, A., Couronce, A.M., Benhanmon, E. and Jungers, P. Timing of hepatitis B revaccination in healthy adults. Lancet 1987, 318, 1206-1207
4. 4 Catterate, A.P. and Murray-Lyon, I.M. Stategies for hepatitis immunisation. Gut 1992, 33, 576-579
5. 5 Coursaget, P., Yvonnet, B., Gilks, W.R. et al. Sheduling of revaccination against hepatitis B virus. Lancet 1991, 337, 1180-1183
6. 6 Grob, P.J., Jilg, W., Milne, A. and Townsend, T.R. Unresolved issues in hepatitis B immunization. In: Procedings of the 1990 International Symposium on Viral Hepatitis and Liver Disease (Eds Hollinger, F.B., Lemon, S.M. and Margolis, H.). Williams and Wilkins, Baltimore, 1991
7. 7 King, J.V., Taylor, E.M., Crow, S.D. et al. Comparison of immunogenicity of hepatitis B vaccine administered intradermally and intramusculary. Rev. Infect. Dis. 1990, 12, 1035-1043
8. 8 Bryan, J.P., Sjogren, M.H., Peine, P.L. and Segters, L.J. Low-dose intradermal and intramuscular vaccination against hepatitis B. CID 1992, 14, 697-707
9. 9 Struve, J., Aronsson, B., Fremming, B., Granath, F., Von sydow, M. and Weiland, O. Intramuscular versus intradermal administration of a recombiant hepatitis B vaccine: a comparison of response rates and analysis of factors influencing the antibody response. Scand. J. Infect. Dis. 1992, 24, 423-429
10. 10 Horowitz, M.M., Ershler, W.B., McKinney, W.P. and Battiola, R.J. Duration of immunity after hepatitis B vaccination: efficacy of low-dose booster vaccine. Ann. Int. Med. 1988, 108, 185-189
11. 11 Bassily, S., Hyans, K.C., El-Ghorab, N. and El-Marsy, N. Hepatitis B vaccination in patients infected with Squistosoma mansonr. duration of immunity and immunogenicity of a low-dose intradermal booster. Trans. R. Soc. Trop. Med. Hyg. 1990, 84, 401-402
12. 12 MacKinney, W.O., Russler, S.K., Horowitz, M.M., Battiola, R.L. and Lee, Mb. Duration of response to intramuscular versus low dose intradermal hepatitis B booster immunization. Infect. Control. Hosp. Epidemiol. 1991, 12, 226-230
13. 13 Thompson, S.C., Darlington, R., Tallnet, D. and Forsythi, J.R. Booster doses of hepatitis B vaccine: response to low-dose inoculations. Med. J. Aust. 1993, 158, 375-378
14. 14 Weber, D.J., Rutala, W.A., Samsa, G.P., Santimaw, J.E. and Lemon, S.M. Obesity as a predictor of poor antibody response to hepatitis B plasma vaccine. J. Am. Med. Assoc. 1985, 254, 3187-3189
15. 15 Fagan, E.A., Tolley, P., Smith, H.M. et al. Hepatitis B immunogenicity and follow-up including two-year booster doses in high-risk health care personnel in a London Teaching Hospital. J. Med. Virol. 1987, 21, 49-56
16. 16 Ostherholm, M.T. and Garayalde, S.M. Clinical viral hepatitis B among Minnesota hospital personnel: results of a 10-year statewide survey. J. Am. Med. Assoc. 1985, 254, 3207-3212
17. 17 Hadler, S.C., Francis, D.P., Maynard, J.E. et al. Long-term immunogenicity and efficacy of hepatitis 8 vaccination in homosexual men. N. Engl. J. Med. 1986, 315, 209-214
18. 18 Resti, M., DiFrancesco, G., Azzari, C., Rossi, M.E. and Viernucci, A. Anti-HBs and immunological memory to HBV vaccine: implication for booster timing. Vaccine 1993, 11, 1079